357 Results (Page 2 of 15)
South Africa Markets Research Reports
South Africa Over The Counter (OTC) Analgesics Market Analysis
This report presents a strategic analysis of the South Africa Over The Counter (OTC) Analgesics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the South Africa Over The Counter (OTC) Analgesics Market, offering unmatched value, accuracy and expert insights.
South Africa COVID-19 Clinical Trials Market Analysis
This report presents a strategic analysis of the South Africa COVID-19 Clinical Trials Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the South Africa COVID-19 Clinical Trials Market, offering unmatched value, accuracy and expert insights.
South Africa Dental Care Market Analysis
The South Africa Dental Care Market size is at around $233.22 Mn in 2022 and is projected to reach $xx Mn in 2030, exhibiting a CAGR of xx% during the forecast period. It was estimated that 12-14% of 35-44-year-olds and 22% of 60-69-year-olds in South Africa had severe periodontal disease, and an estimated 30% of the population in South Africa suffering from the decay of their permanent teeth which causes high demand of dental services that are only forecasted to rise in future. The market is captured by players like Netcare, Medicross, Dental365, and Smile Dental. This report by Insights10 is segmented by treatment type, age group, and clinical setup, and by demography.
South Africa In Vitro Fertilisation (IVF) Service Market Analysis
This report presents a strategic analysis of the South Africa In Vitro Fertilisation (IVF) Service Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the South Africa In Vitro Fertilisation (IVF) Service Market, offering unmatched value, accuracy and expert insights.
South Africa Chronic Pain Therapeutics Market Analysis
The South Africa Chronic Pain Therapeutics Market is anticipated to experience a growth from $483 Mn in 2022 to $838 Mn by 2030, with a CAGR of 7.13% during the forecast period of 2022-2030. The key drivers of the chronic pain therapeutics market include the increasing prevalence of chronic pain conditions, the continual progress in medical technology leading to innovative solutions, and heightened public awareness and education. The South Africa Chronic Pain Therapeutics Market encompasses various players across different segments, including Pfizer, GlaxoSmithKline, Novartis, Sanofi, AstraZeneca, Merck, Johnson and Johnson, Teva, Cipla, Mankind Pharma, etc., among various others.
South Africa Artificial Intelligence (AI) in Healthcare Market Analysis
South Africa's Artificial Intelligence (AI) In Healthcare Market is projected to grow from $0.04 Bn in 2022 to $0.95 Bn by 2030, registering a CAGR of 46.45% during the forecast period of 2022-30. The market will be driven by the country's high burden of disease and advanced telecommunications infrastructure. The market is segmented by healthcare components & by healthcare applications. Some of the major players include GE Healthcare, Vantage Health Technologies & Iyeza Health.
South Africa Digital Therapeutics Market Analysis
South Africa Digital Therapeutics Market is at around $40 Mn in 2023 and is projected to reach $230.53 Mn in 2030, exhibiting a CAGR of 28.43 % during the forecast period. The market is growing as a result of the rising prevalence of chronic diseases, rising technology adoption, and government initiatives. The market is dominated by key players like LifeQ, Wellevate Health, Omada Health Inc., DarioHealth Corp., 2Morrow Inc., Livongo Health Inc., WellDoc, Propeller Health, Canary Health, Noom Inc., Akili Interactive Labs Inc., and Hygieia.
South Africa Artificial Intelligence (AI) in Diagnostics Market Analysis
South Africa's Artificial Intelligence (AI) in the diagnostics market is projected to grow from $6.5 Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022-2030. The market will be driven by rising demand for personalized healthcare, as well as the need to address health inequities and resource limitations. The market is segmented by component & by diagnosis. Some of the major players include IBM Watson Health, Siemens Healthineers & Envisionit Deep AI
South Africa Skin Antiseptic Products Market Analysis
This report presents a strategic analysis of the South Africa Skin Antiseptic Products Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the South Africa Skin Antiseptic Products Market, offering unmatched value, accuracy and expert insights.
South Africa Insulin Market Analysis
This report presents a strategic analysis of the South Africa Insulin Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the South Africa Insulin Market, offering unmatched value, accuracy and expert insights.
South Africa Cardiovascular Drugs Market Analysis
South Africa Cardiovascular Drug Market is at around $0.9 Bn in 2022 and is projected to reach $1.3 Bn in 2030, exhibiting a CAGR of 5.03% during the forecast period. The market is expanding as a result of the rise in research and development, government initiatives, and the burden of cardiovascular diseases. The market is dominated by key players like Aspen Pharmacare, Adcock Ingram, Cipla Medpro, Bristol-Myers Squibb Co., F. Hoffman-La Roche, Pfizer Inc., Astra Zeneca, Merck & Co., Sanofi, Novartis, and GSK.
South Africa Lung Cancer Drugs Market Analysis
This report presents a strategic analysis of the South Africa Lung Cancer Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the South Africa Lung Cancer Drugs Market, offering unmatched value, accuracy and expert insights.
South Africa Cholesterol Therapeutics Market Analysis
The South Africa Cholesterol Therapeutics Market is anticipated to experience a growth from $157.9 Mn in 2022 to $213.3 Mn by 2030, with a CAGR of 3.83% during the forecast period of 2022-2030. The key drivers of the market include continuous advancements in pharmaceutical research leading to innovative medications, improved healthcare accessibility through developing infrastructure, and the increasing demand driven by changing lifestyles and urbanization-related health challenges. The South Africa Cholesterol Therapeutics Market encompasses various players across different segments such as Pfizer, Merck, Sanofi, AstraZeneca, Bayer, Novartis, Aspen, Adcock Ingram, Sun Pharma, Ranbaxy, etc., among various others.
South Africa Cardiac Arrhythmia Therapeutics Market Analysis
South Africa Cardiac Arrhythmia Therapeutics Market valued at $47 Mn in 2022, projected to reach $81 Mn by 2030 with a 7.03% CAGR. The key drivers of this industry include the rising burden of cardiovascular diseases, technological advancements, and supportive government policies. The industry is primarily dominated by players such as Abbott, Pfizer, MediRite, Clicks Group, Ascendis, Dis-Chem, and Medtronic among others.
South Africa Over The Counter (OTC) Pharmaceuticals Market Analysis
South Africa's over-the-counter (OTC) pharmaceuticals market size was valued at $893.8 Mn in 2022 and is estimated to expand at a CAGR of 6.54% from 2022 to 2030 and will reach $1483.6 Mn in 2030. OTC are non-prescription medications and are a vital component of the healthcare system, offering consumers accessible solutions for a wide range of common health issues. The market is segmented by product type and distribution channel. The key market players are Johnson and Johnson Services Inc (USA), Bayer AG (Germany), Novartis AG (Switzerland) and others.
South Africa Castrate Resistant Prostate Cancer Therapeutics Market Analysis
South Africa Castrate Resistant Prostate Cancer Therapeutics Market valued at $66 Mn in 2022, projected to reach $126 Mn by 2030 with a 8.33% CAGR. The key drivers of the market in South Africa include the increasing prevalence of prostate cancer, limited affordability and healthcare access creating an opportunity for generic drug manufacturers, and the combined effects of heightened awareness, improved diagnostics, and expanded treatment availability driving early detection and long-term management demand. The South Africa Castrate Resistant Prostate Cancer Therapeutics Market encompasses various players across different segments, including Pfizer, Johnson & Johnson, Roche, Bayer, AstraZeneca, Sanofi, Aspen, Novartis, Cipla, Dr Reddy’s, etc, among various others.
South Africa Alzheimer’s Therapeutics Market Analysis
South Africa alzheimer’s therapeutics market valued at $31 Mn in 2022, projected to reach $69 Mn by 2030 with a 10.33% CAGR. The growing prevalence of Alzheimer's disease, which is fuelled by an aging population, is the main factor driving the market for drugs used to treat the condition. The leading pharmaceutical companies currently working in the industry are Pfizer, Eisai, Biogen, Merck & Co., Novartis, Roche, Johnson & Johnson, Eli Lilly, AstraZeneca and GlaxoSmithKline.
South Africa Infectious Disease Drugs Market Analysis
South Africa Infectious Disease Drugs Market valued at $0.77 Bn in 2023, projected to reach $1.12 Bn by 2030 with a 5.50% CAGR. The market is expanding due to factors such as high disease burden, government initiatives, and international partnerships and investments. The market is dominated by key players like Aspen Pharmacare, GlaxoSmithKline plc, Johnson & Johnson, Abbott Laboratories, Merck & Co., Mylan N.V., Cipla Limited, Roche Diagnostics, Sanofi, and Pfizer.
South Africa Atopic Dermatitis Therapeutics Market Analysis
The South Africa Atopic Dermatitis Therapeutics Market was valued at US $80 Mn in 2022, and is predicted to grow at (CAGR) of 10.03% from 2023 to 2030, to US $172 Mn by 2030. The key drivers of this industry include the increased burden of Atopic Dermatitis (AD), increasing government initiatives, and untapped market potential. The industry is primarily dominated by players such as Sanofi, Pfizer, Regeneron, Astellas, Novartis, Meda, and Allergan, among others.
South Africa Atherosclerosis Therapeutics Market Analysis
South Africa Atherosclerosis Therapeutics Market was valued at $18 Mn in 2022 and is estimated to reach $31 Mn in 2030, exhibiting a CAGR of 6.93% during the forecast period. The increasing prevalence of cardiovascular diseases, aggravated by unhealthy dietary patterns, sedentary lifestyles, and a growing aging population worldwide, is anticipated to increase the need for atherosclerosis therapeutics. Leading pharmaceutical companies currently operating in the industry are Pfizer, Novartis, Sanofi, AstraZeneca, Merck Sharp & Dohme, Bayer, Johnson & Johnson, Aspen Pharmacare, Cipla Medpro and Adcock Ingram.
South Africa Asthma and COPD Therapeutics Market Analysis
The South Africa Asthma and COPD Therapeutics Market was valued at US $217 Mn in 2022, and is predicted to grow at (CAGR) of 6.43% from 2023 to 2030, to US $357 Mn by 2030. The key drivers of this industry include the surge in the prevalence of COPD and asthma, supportive government initiatives, technological advancements, and others. The industry is primarily dominated by players such as Abbott, Aspen, AstraZeneca, Adcock, Novartis, Netcare, and GSK, among others.
South Africa HIV Drugs Market Analysis
South Africa HIV Drugs Market is at around $0.21 Bn in 2023 and is projected to reach $0.29 Bn in 2030, exhibiting a CAGR of 4.83% during the forecast period. The expansion of the market is due to factors such as collaboration and partnership with foreign organizations, the increasing prevalence of HIV/ Aids, and technological advancements in the field. The market is dominated by key players like Aspen Pharmacare, Adcock Ingram, Gilead Sciences, ViiV Healthcare, Boehringer Ingelheim International GmbH, Janssen Pharmaceuticals, Merck & Co., Bristol-Myers Squibb, AbbVie Inc., F. Hoffmann-La Roche Ltd., and Novartis.
South Africa Antifungal Drugs Market Analysis
South Africa Antifungal Drugs Market is at around $0.103 Bn in 2023 and is projected to reach $0.145 Bn in 2030, exhibiting a CAGR of 5.03% during the forecast period. The HIV/AIDS Epidemic, rising fungus infections, government initiatives, and healthcare spending are fueling the market's expansion. The market is dominated by key players like Aspen Pharmacare Holdings Limited, Abbott Laboratories, GlaxoSmithKline plc, Pfizer Inc., Merck & Co., Novartis AG, Astellas Pharma Inc., Sanofi S.A., Bayer AG, Glenmark Pharmaceuticals Limited, and Gilead Sciences Inc.
South Africa Lactoferrin Market Analysis
South Africa lactoferrin market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Technology advances that enable effective operational maintenance, efficient production, an extended product line, elegant design and packaging, and sales monitoring are key growth factors for the lactoferrin industry. The major key players in this market are Hilmar Cheese Company, Pharming Group NV, FrieslandCamina, Synlait Milk Ltd., Ingredia SA, MP Biomedicals, Tatura Milk Industries Ltd., Glanbia plc, APS BioGroup, ProHealth, Fonterra Cooperative Group Ltd., Farbest Brands, InVitria, Milei GmbH, Ferrin-tech LLC.
South Africa Lipid Lowering Drugs Market Analysis
South Africa lipid lowering drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The increase in heart disease cases, higher awareness of the health risks associated with high cholesterol levels, and the availability of effective treatments are key factors driving the global market for lipid-lowering pharmaceuticals. The major key players in this market are Sanofi, Sun Pharmaceutical Industries Ltd., AstraZeneca, Pfizer Inc., Novartis AG, AbbVie Inc., Merck & Co. Inc., Amgen Inc., and Dr. Reddy's.
